The miR-21/SP1/DNMT1 positive feedback loop in MSCs triggered by glioma exosomal CD44 could increase MSC exosomal miR-21 to a dozen times that in glioma exosomes, amplifying glioma exosomal immunosuppressive signaling. The gene discussed is CD44; the disease is central nervous system cancer.